{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:15:35Z","timestamp":1772126135926,"version":"3.50.1"},"reference-count":33,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n<jats:p>The COVID-19 pandemic has profoundly influenced the effort to achieve global health equity. This has been particularly the case for HIV\/AIDS, tuberculosis, and malaria control initiatives in low- and middle-income countries, with significant outcome setbacks seen for the first time in decades. Lost in the calls for compensatory funding increases for such programs, however, is the plight of endemic tropical heart diseases, a group of disorders that includes rheumatic heart disease, Chagas disease, and endomyocardial fibrosis. Such endemic illnesses affect millions of people around the globe and remain a source of substantial mortality, morbidity, and health disparity. Unfortunately, these conditions were already neglected before the pandemic, and thus those living with them have disproportionately suffered during the time of COVID-19. In this perspective, we briefly define endemic tropical heart diseases, summarizing their prepandemic epidemiology, funding, and control statuses. We then describe the ways in which people living with these disorders, along with the healthcare providers and researchers working to improve their outcomes, have been harmed by the ongoing COVID-19 pandemic. We conclude by proposing the path forward, including approaches we may use to leverage lessons learned from the pandemic to strengthen care systems for these neglected diseases.<\/jats:p>","DOI":"10.4269\/ajtmh.22-0514","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T15:35:48Z","timestamp":1675697748000},"page":"462-464","source":"Crossref","is-referenced-by-count":3,"title":["What We Lost in the Fire: Endemic Tropical Heart Diseases in the Time of COVID-19"],"prefix":"10.4269","volume":"108","author":[{"given":"Andrew Y.","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Population Health, Stanford University, Stanford, California;"},{"name":"Stanford Cardiovascular Institute, Stanford University, Stanford, California;"},{"name":"Center for Innovation in Global Health, Stanford University, Stanford, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesl","family":"Z\u00fchlke","sequence":"additional","affiliation":[{"name":"South African Medical Research Council, Cape Town, South Africa;"},{"name":"Division of Paediatric Cardiology, Red Cross War Memorial Children\u2019s Hospital, University of Cape Town, Cape Town, South Africa;"},{"name":"Cape Heart Institute, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Luiz P.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Telehealth Center and Cardiology Service, Hospital das Cl\u00ednicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil;"},{"name":"Department of Internal Medicine, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Barry","sequence":"additional","affiliation":[{"name":"Center for Innovation in Global Health, Stanford University, Stanford, California;"},{"name":"Department of Medicine, Stanford University School of Medicine, Stanford, California;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmy","family":"Okello","sequence":"additional","affiliation":[{"name":"Department of Adult and Pediatric Cardiology, Uganda Heart Institute, Kampala, Uganda;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris T.","family":"Longenecker","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington;"},{"name":"Department of Global Health, University of Washington, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"b1","year":"2021"},{"key":"b2","author":"Buissonniere","year":"2022"},{"key":"b3","year":"2022"},{"key":"b4","series-title":"J Am Coll Cardiol","first-page":"2982","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020"},{"key":"b5","series-title":"PLoS Negl Trop Dis","first-page":"e97","article-title":"Endomyocardial fibrosis: still a mystery after 60 years","volume":"2","author":"Bukhman","year":"2008"},{"key":"b6","series-title":"Trends Parasitol","first-page":"583","article-title":"The future of Chagas disease control","volume":"22","author":"Schofield","year":"2006"},{"key":"b7","series-title":"Disease Control Priorities in Developing Countries","author":"Remme"},{"key":"b8","series-title":"Trans R Soc Trop Med Hyg","first-page":"287","article-title":"Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease","volume":"113","author":"Macleod","year":"2019"},{"key":"b9","series-title":"N Engl J Med","first-page":"713","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990\u20132015","volume":"377","author":"Watkins","year":"2017"},{"key":"b10","series-title":"Lancet HIV","first-page":"e361","article-title":"Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132015: the Global Burden of Disease Study 2015","volume":"3","author":"Wang","year":"2016"},{"key":"b11","series-title":"Glob Heart","first-page":"26","article-title":"WHF IASC roadmap on Chagas disease","volume":"15","author":"Echeverr\u00eda","year":"2020"},{"key":"b12","series-title":"Circulation","first-page":"2503","article-title":"Tropical endomyocardial fibrosis: natural history, challenges, and perspectives","volume":"133","author":"Grimaldi","year":"2016"},{"key":"b13","series-title":"J Am Coll Cardiol","first-page":"173","article-title":"International impact of COVID-19 on the diagnosis of heart disease","volume":"77","author":"Einstein","year":"2021"},{"key":"b14","series-title":"J Intern Med.","first-page":"450","article-title":"The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review","volume":"289","author":"Chang","year":"2020"},{"key":"b15","series-title":"J Am Coll Cardiol","first-page":"2871","article-title":"Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic","volume":"75","author":"Garcia","year":"2020"},{"key":"b16","series-title":"Am Heart J","first-page":"14","article-title":"Cardiovascular procedural deferral and outcomes over COVID-19 pandemic phases: a multi-center study","volume":"241","author":"Yong","year":"2021"},{"key":"b17"},{"key":"b18","author":"Ritchie","year":"2020"},{"key":"b19","year":"2021"},{"key":"b20","series-title":"Med J Aust","first-page":"583","article-title":"Doctors with borders: the impact of international border closures on Timorese people who need cardiac procedures","volume":"216","author":"Paratz","year":"2022"},{"key":"b21","series-title":"Eur Heart J","first-page":"4085","article-title":"Rheumatic heart disease and COVID-19","volume":"41","author":"Beaton","year":"2020"},{"key":"b22","series-title":"N Engl J Med","first-page":"1899","article-title":"Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease","volume":"370","author":"Molina","year":"2014"},{"key":"b23","series-title":"Clin Infect Dis","first-page":"e69","article-title":"Tolerance and safety of nifurtimox in patients with chronic Chagas disease","volume":"51","author":"Jackson","year":"2010"},{"key":"b24","series-title":"J Am Coll Cardiol","first-page":"1397","article-title":"Rheumatic heart disease worldwide","volume":"72","author":"Watkins","year":"2018"},{"key":"b25","series-title":"Eur Heart J","first-page":"3164","article-title":"The collateral damage of COVID-19 to cardiovascular services: a meta-analysis","volume":"44","author":"Nadarajah","year":"2022"},{"key":"b26","series-title":"PLoS One","first-page":"e0194030","article-title":"Motivations of women in Uganda living with rheumatic heart disease: a mixed methods study of experiences in stigma, childbearing, anticoagulation, and contraception","volume":"13","author":"Chang","year":"2018"},{"key":"b27","series-title":"Lancet","first-page":"2385","article-title":"The Lancet Women and Cardiovascular Disease Commission: reducing the global burden by 2030","volume":"397","author":"Vogel","year":"2021"},{"key":"b28","series-title":"AIDS","first-page":"S107","article-title":"Building on the HIV chronic care platform to address noncommunicable diseases in sub-Saharan Africa: a research agenda","volume":"32 (Suppl 1):","author":"Vorkoper","year":"2018"},{"key":"b29","year":"2019"},{"key":"b30","series-title":"Circ Cardiovasc Qual Outcomes","first-page":"e008445","article-title":"Mortality along the rheumatic heart disease cascade of care in Uganda","volume":"15","author":"Chang","year":"2022"},{"key":"b31","series-title":"NPJ Vaccines","first-page":"84","article-title":"Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice","volume":"6","author":"Mallory","year":"2021"},{"key":"b32","year":"2022"},{"key":"b33","series-title":"Nature","first-page":"S30","article-title":"An mRNA vaccine industry in the making","volume":"598","author":"Savage","year":"2021"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/108\/3\/article-p462.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/108\/3\/article-p462.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/108\/3\/article-p462.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T13:57:42Z","timestamp":1677679062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/108\/3\/article-p462.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":33,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.22-0514","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}